Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene

Molecular Immunology - Tập 77 - Trang 89-96 - 2016
Xue Xiao1,2, Cybele Ghossein3, Agustín Tortajada4, Yuzhou Zhang2, Nicole C. Meyer2, Michael P. Jones2, Nicolò Ghiringhelli Borsa2, Carla Nester5,2, Christie P. Thomas5,6, Santiago Rodrı́guez de Córdoba4, Richard J. Smith5,1,6,2
1Interdepartmental PhD Program in Genetics, Caver College of Medicine, University of Iowa, Iowa City, IA, USA
2Molecular Otolaryngology and Renal Research Laboratories, Caver College of Medicine, University of Iowa, Iowa City, IA, USA
3Department of Medicine, Division of Nephrology and Hypertension Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
4Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas and Centro de Investigación Biomédica en Enfermedades Raras, Madrid, Spain
5Departments of Pediatrics and Internal Medicine, Divisions of Nephrology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA
6Iowa Institute of Human Genetics, Caver College of Medicine, University of Iowa, Iowa City, IA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abrera-Abeleda, 2006, Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease), J. Med. Genet., 43, 582, 10.1136/jmg.2005.038315

Abrera-Abeleda, 2011, Allelic variants of complement genes associated with dense deposit disease, J. Am. Soc. Nephrol., 22, 1551, 10.1681/ASN.2010080795

Athanasiou, 2011, Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees, Clin. J. Am. Soc. Nephrol., 6, 1436, 10.2215/CJN.09541010

Bu, 2015, High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies, J. Am. Soc. Nephrol.

Chen, 2014, Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J. Clin. Invest., 124, 145, 10.1172/JCI71866

Colville, 2003, Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II (dense deposit disease), Am. J. Kidney Dis., 42, E2, 10.1016/S0272-6386(03)00665-6

Gale, 2010, Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, Lancet, 376, 794, 10.1016/S0140-6736(10)60670-8

Goicoechea de Jorge, 2013, Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc. Natl. Acad. Sci. U. S. A., 110, 4685, 10.1073/pnas.1219260110

Jozsi, 2014, Factor H-related proteins, Methods Mol. Biol., 1100, 225, 10.1007/978-1-62703-724-2_18

Leys, 1991, Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients, Graefes Arch. Clin. Exp. Ophthalmol., 229, 406, 10.1007/BF00166300

Lu, 2012, Clinical features and outcomes of 98 children and adults with dense deposit disease, Pediatr. Nephrol., 27, 773, 10.1007/s00467-011-2059-7

Malik, 2012, A hybrid CFHR3-1 gene causes familial C3 glomerulopathy, J. Am. Soc. Nephrol., 23, 1155, 10.1681/ASN.2012020166

Medjeral-Thomas, 2014, A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry, Kidney Int., 85, 933, 10.1038/ki.2013.348

Medjeral-Thomas, 2014, C3 glomerulopathy: clinicopathologic features and predictors of outcome, Clin. J. Am. Soc. Nephrol., 9, 46, 10.2215/CJN.04700513

Montes, 2008, Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis, Mol. Immunol., 45, 2897, 10.1016/j.molimm.2008.01.027

Neary, 2002, Familial membranoproliferative glomerulonephritis type III, Am. J. Kidney Dis., 40, E1, 10.1053/ajkd.2002.33932

Neary, 2002, Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1, J. Am. Soc. Nephrol., 13, 2052, 10.1097/01.ASN.0000022006.49966.F8

Pickering, 2013, C3 glomerulopathy: consensus report, Kidney Int., 84, 1079, 10.1038/ki.2013.377

Servais, 2007, Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome, J. Med. Genet., 44, 193, 10.1136/jmg.2006.045328

Servais, 2012, Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int., 82, 454, 10.1038/ki.2012.63

Servais, 2013, C3 glomerulopathy, Contrib. Nephrol., 181, 185, 10.1159/000348654

Sethi, 2009, Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway, Kidney Int., 75, 952, 10.1038/ki.2008.657

Sethi, 2010, Dense deposit disease associated with monoclonal gammopathy of undetermined significance, Am. J. Kidney Dis., 56, 977, 10.1053/j.ajkd.2010.06.021

Sethi, 2012, C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up, Kidney Int., 82, 465, 10.1038/ki.2012.212

Skerka, 2013, Complement factor H related proteins (CFHRs), Mol. Immunol., 56, 170, 10.1016/j.molimm.2013.06.001

Tortajada, 2013, C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J. Clin. Invest., 123, 2434, 10.1172/JCI68280

Zhang, 2012, Causes of alternative pathway dysregulation in dense deposit disease, Clin. J. Am. Soc. Nephrol., 7, 265, 10.2215/CJN.07900811

Zhang, 2014, Defining the complement biomarker profile of C3 glomerulopathy, Clin. J. Am. Soc. Nephrol., 9, 1876, 10.2215/CJN.01820214

Thông tin
Thông tin xuất bản

Molecular Immunology

Tập 77

89-96

Thông tin tác giả